Ethanol promotes rat aortic vascular smooth muscle cell proliferation via increase of homocysteine and oxidized-low-density lipoprotein

Journal of Cardiology

Volumn 62, Issue 6, 2013, Pages 374-378

  Shirpoor, Alireza ^a   Salami, Siamak ^b   Khadem Ansari, Mohammad Hasan ^a   Ilkhanizadeh, Behrouz ^a   Abdollahzadeh, Naseh ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ethanol; Homocysteine; Oxidized low density lipoprotein; Rat; Vascular smooth muscle cell

Indexed keywords

ALCOHOL; APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; CYCLINE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LIPID BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STAINING; VASCULAR SMOOTH MUSCLE;

ETHANOL; HOMOCYSTEINE; OXIDIZED-LOW-DENSITY LIPOPROTEIN; RAT; VASCULAR SMOOTH MUSCLE CELL;

ALCOHOL DRINKING; ANIMALS; AORTA; ATHEROSCLEROSIS; CELL PROLIFERATION; ETHANOL; HOMOCYSTEINE; LIPOPROTEINS, LDL; MALE; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RATS; RATS, WISTAR; RISK FACTORS; TIME FACTORS;

EID: 84892439189     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.06.003     Document Type: Article

References (48)

1. Kisters K., Schodjaian K., Tokmak F., Kosch M., Rahn K.H. Effect of ethanol on blood pressure-role of magnesium. Am J Hypertens 2000, 13:455-456.
2. O'Callaghan C.J., Phillips P.A., Krum H., Howes L.G. The effects of short-term alcohol intake on clinic and ambulatory blood pressure in normotensive 'social' drinkers. Am J Hypertens 1995, 8:572-577.
3. Shirpoor A., Salami S., Khadem-Ansari M.H., Heshmatian B., Ilkhanizadeh B. Long-term ethanol consumption initiates atherosclerosis in rat aorta through inflammatory stress and endothelial dysfunction. Vascul Pharmacol 2012, 57:72-77.
4. Rantakomi S.H., Laukkanen J.A., Kurl S., Kauhanen J. Binge drinking and the progression of atherosclerosis in middle-aged men: an 11-year follow-up. Atherosclerosis 2009, 205:266-271.
5. Shirpoor A., Salami S., Khadem-Ansari M.H., Minassian S., Yegiazarian M. Protective effect of vitamin E against ethanol-induced hyperhomocysteinemia, DNA damage, and atrophy in the developing male rat brain. Alcohol Clin Exp Res 2009, 33:1181-1186.
6. Shirpoor A., Minassian S., Salami S., Khadem-Ansari M.H., Yeghiazaryan M. Alpha-lipoic acid decreases DNA damage and oxidative stress induced by alcohol in the developing hippocampus and cerebellum of rat. Cell Physiol Biochem 2008, 22:769-776.
7. Haorah J., Knipe B., Leibhart J., Ghorpade A., Persidsky Y. Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J Leukoc Biol 2005, 78:1223-1232.
8. Sharma M., Rai S.K., Tiwari M., Chandra R. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur J Pharmacol 2007, 574:49-60.
9. Marraccini J.V., Lentz K., McKenney M.G. Blood pressure effects of thoracic gunshot wounds: the role of bullet image diameter. Am Surg 2001, 67:354-356.
10. Mahalle N., Kulkarni M.V., Garg M.K., Naik S.S. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J Cardiol 2013, 61:289-294.
11. Dayal S., Arning E., Bottiglieri T., Boger R.H., Sigmund C.D., Faraci F.M., Lentz S.R. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 2004, 35:1957-1962.
12. Cui Y., Blumenthal R.S., Flaws J.A., Whiteman M.K., Langenberg P., Bachorik P.S., Bush T.L. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001, 161:1413-1419.
13. Ono K. Current concept of reverse cholesterol transport and novel strategy for atheroprotection. J Cardiol 2012, 60:339-343.
14. Zakynthinos E., Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009, 53:317-333.
15. Brown M.S., Goldstein J.L. How LDL receptors influence cholesterol and atherosclerosis. Sci Am 1984, 251:58-66.
16. Chobanian A.V. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia coexist. Hypertension 1991, 18:130-131.
17. Xavier H.T., Abdalla D.S., Martinez T.L., Ramires J.A., Gagliardi A.R. Effects of oxidized LDL on in vitro proliferation and spontaneous motility of human coronary artery endothelial cells. Arq Bras Cardiol 2004, 83:493-497. 88-92.
18. Pastorello E.A., Ortolani C., Baroglio C., Pravettoni V., Ispano M., Giuffrida M.G., Fortunato D., Farioli L., Monza M., Napolitano L., Sacco M., Scibola E., Conti A. Complete amino acid sequence determination of the major allergen of peach (Prunus persica) Pru p 1. Biol Chem 1999, 380:1315-1320.
19. Hiki M., Shimada K., Ohmura H., Kiyanagi T., Kume A., Sumiyoshi K., Fukao K., Inoue N., Mokuno H., Miyazaki T., Daida H. Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease. J Cardiol 2009, 53:108-116.
20. Bjorkerud B., Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol 1996, 16:416-424.
21. Steinberg D., Pearson T.A., Kuller L.H. Alcohol atherosclerosis. Ann Intern Med 1991, 114:967-976.
22. Dicker E., Cederbaum A.I. NADH-dependent generation of reactive oxygen species by microsomes in the presence of iron and redox cycling agents. Biochem Pharmacol 1991, 42:529-535.
23. Le Lan C., Ropert M., Laine F., Medevielle M., Jard C., Pouchard M., Le Treut A., Moirand R., Loreal O., Brissot P. Serum ceruloplasmin and ferroxidase activity are not decreased in hepatic failure related to alcoholic liy. Alcohol Clin Exp Res 2004, 28(5):775-779.
24. Croft K.D., Puddey I.B., Rakic V., Abu-Amsha R., Dimmitt S.B., Beilin L.J. Oxidative susceptibility of low-density lipoproteins-influence of regular alcohol use. Alcohol Clin Exp Res 1996, 20:980-984.
25. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006, 65:278-290.
26. Chen C., Halkos M.E., Surowiec S.M., Conklin B.S., Lin P.H., Lumsden A.B. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res 2000, 88:26-33.
27. Desai A., Lankford H.A., Warren J.S. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation 2001, 25:179-186.
28. da Cunha A.A., Ferreira A.G., da Cunha M.J., Pederzolli C.D., Becker D.L., Coelho J.G., Dutra-Filho C.S., Wyse A.T. Chronic hyperhomocysteinemia induces oxidative damage in the rat lung. Mol Cell Biochem 2011, 358:153-160.
29. Stuhlinger M.C., Tsao P.S., Her J.H., Kimoto M., Balint R.F., Cooke J.P. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001, 104:2569-2575.
30. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986, 77:1370-1376.
31. Miyazaki H., Matsuoka H., Cooke J.P., Usui M., Ueda S., Okuda S., Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. J Cardiol 1999, 33:105-106.
32. Liu X., Shen J., Zhan R., Wang X., Wang X., Zhang Z., Leng X., Yang Z., Qian L. Proteomic analysis of homocysteine induced proliferation of cultured neonatal rat vascular smooth muscle cells. Biochim Biophys Acta 2009, 1794:177-184.
33. Lee C.K., Park H.J., So H.H., Kim H.J., Lee K.S., Choi W.S., Lee H.M., Won K.J., Yoon T.J., Park T.K., Kim B. Proteomic profiling and identification of cofilin responding to oxidative stress in vascular smooth muscle. Proteomics 2006, 6:6455-6475.
34. McGregor E., Kempster L., Wait R., Gosling M., Dunn M.J., Powell J.T. F-actin capping (CapZ) and other contractile saphenous vein smooth muscle proteins are altered by hemodynamic stress: a proteonomic approach. Mol Cell Proteomics 2004, 3:115-124.
35. Boccardi C., Cecchettini A., Caselli A., Camici G., Evangelista M., Mercatanti A., Rainaldi G., Citti L. A proteomic approach to the investigation of early events involved in the activation of vascular smooth muscle cells. Cell Tissue Res 2007, 329:119-128.
36. Trapani V., Farruggia G., Marraccini C., Iotti S., Cittadini A., Wolf F.I. Intracellular magnesium detection: imaging a brighter future. Analyst 2010, 135:1855-1866.
37. Shimada K., Mokuno H., Matsunaga E., Miyazaki T., Sumiyoshi K., Kume A., Miyauchi K., Daida H. Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease. Diabetes Care 2004, 27:843-844.
38. Munzel T., Gori T., Bruno R.M., Taddei S. Is oxidative stress a therapeutic target in cardiovascular disease?. Eur Heart J 2010, 31:2741-2748.
39. Miri R., Saadati H., Ardi P., Firuzi O. Alterations in oxidative stress biomarkers associated with mild hyperlipidemia and smoking. Food Chem Toxicol 2012, 50:920-926.
40. Brizzi P., Tonolo G., Carusillo F., Malaguarnera M., Maioli M., Musumeci S. Plasma lipid composition and LDL oxidation. Clin Chem Lab Med 2003, 41:56-60.
41. Marcovina S., Packard C.J. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 2006, 259:437-446.
42. Walldius G., Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med 2006, 259:493-519.
43. Curcelli E.C., Muller S.S., Novelli Filho J.L. Beneficial effects of diclofenac therapy on serum lipids, oxidized low-density lipoprotein and antioxidant defenses in rats. Life Sci 2008, 82:892-898.
44. Tamada K., Shimozaki K., Chapoval A.I., Zhai Y., Su J., Chen S.F., Hsieh S.L., Nagata S., Ni J., Chen L. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 2000, 164:4105-4110.
45. Scott-Burden T., Resink T.J., Hahn A.W., Baur U., Box R.J., Buhler F.R. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem 1989, 264:12582-12589.
46. Natarajan V., Scribner W.M., Hart C.M., Parthasarathy S. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res 1995, 36:2005-2016.
47. Galle J., Schneider R., Heinloth A., Wanner C., Galle P.R., Conzelmann E., Dimmeler S., Heermeier K. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney Int 1999, 55:1450-1461.
48. Lopes-Virella M.F., Baker N.L., Hunt K.J., Lachin J., Nathan D., Virella G. Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes. Atherosclerosis 2011, 214:462-467.